ClinicalTrials.gov
public full text
Public Domain
Pharmacogenomics of Heparin-Induced Thrombocytopenia
The purpose of this research is to identify genomic markers that can predict heparin-induced thrombocytopenia (HIT), which is a very serious side effect to heparin. Heparin is commonly used to prevent blood clots and the investigators may be able to identify genomic markers which can be used to prevent heparin use in people who will get HIT.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Heparin Binding Protein as a Prognostic Biomarker of Sepsis Severity#966392
- Letter to the editors: "Thromboelastography to monitor anticoagulation in ICU patients receiving a continuous infusion of unfractionated heparin"#254359
- HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)#915912
- Assessment of Heparin Binding Protein for the Prediction of Severe Sepsis#321601
- Comprehensive review and early detection strategies for severe fever with thrombocytopenia: insights from epidemiology, diagnostics, and evolving research with machine learning.#247589
Record · ID 1320622
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive